TORS is the pneumonic for trans-oral robotic surgery. It is a minimally invasive approach, carried out through the mouth, using surgeon controlled robotic arms. Various 5 mm and 8 mm instruments and a 3-D HD camera arm allow for surgical dissection, bleeding control, and suture or flap repair, if necessary.

The cancers of oropharynx (base of tongue, tonsil, etc), hypopharynx and supra-glottic larynx are the ones which benefit from this surgery.

Advantages of TORS over open surgery:

  • Least PAIN & DISCOMFORT
  • Less BLOOD LOSS
  • COSMETICALLY SUPERIOR as there is no wound over the face and neck
  • Shorter length of anesthesia used
  • Normal functions (SPEECH AND SWALLOWING) return back in not time.
  • Elimination of Chemoradiation in some cases.
  • short hospital STAY
  • Quicker return to NORMAL LIFE & WORK
  • Least wound COMPLICATIONS.

 

  • Non-surgical alternate treatment

    Presently most of the patients are undergoing chemotherapy and radiation(chemoradiation) due to lack of robot and skilled team. Though chemoradiation avoids surgery, there are many long-term complications that last lifelong.

    • Swallowing dysfunction -permanent feeding tube dependence in 19 -30% of patients
    • A constriction in foodpipe (Pharyngeal strictures)
    • Dry mouth which is life long
    • Chronic pain in the head and neck
    • Bone related problems (Osteoradionecrosis)
    • when chemo-radiation does not cure the condition or the disease comes back, the surgery is complicated.

    These are the reasons why TORS is emerging as a major modality of treatment for these cancers.

  • Laser surgery: how does it differ?

    Transoral laser microsurgery is also considered a minimally invasive approach with similar indications. However, there are many limitations to it. As the surgeon operates using long unstable instruments, the removal of cancer is usually not satisfactory. Laser is good for early cancers of larynx. However, for other cancers listed above, the utility of laser is questionable.

  • Who are the candidates for tors?

    The best patients for TORS generally include early tumors (smaller than 4 cm in size) of the oropharynx (base of tongue and tonsil) and laryngopharynx (supraglottis and pharyngeal wall). These patients do very well with TORS, many of the getting cure just with this surgery alone. Some may need further treatment like radiation with or without chemotherapy, however, the dose that would be required will be much lower and tolerable.Some selected patients with tumours larger than 4 cm may also benefit from TORS. However, these patients are selected carefully.

    The patients who have had recurrence of cancer following chemoradiation or for tumors left behind after completion of chemoradiation had no hope before TORS came into picture. Today these patients do well with the help of this new technology.

    If statistically significant risk to the neck for spread of tumor exists, or if clinically evident neck nodal disease is present, neck dissection is usually performed during or 1 to 3 weeks after the TORS procedure. This surgery can be performed by minimally invasive technique called MIND.

    Following TORS and neck dissection, about 70% of patients can be spared chemotherapy and approximately 30% can avoid radiation treatment based on histologic findings. The radiation dose that is required also is much lower than the conventional. This avoids many of the long-term complications associated with conventional chemo-radiotherapy.

Consult Team MACS at

CONSULTATION AT

MACS Clinic

#350, 1st Floor, 2nd Cross, 1st Block, Near Ashoka Pillar, Behind PTA School, Jayanagar Bangalore-560011,
Karnataka, India

  Google Map

HCG (Center for Robotics)

Ground Floor, Tower 3, HCG Hospital,P.Kalinga Rao Road, Sampangiram Nagar, Bengaluru, Karnataka 560027

  Google Map

Fortis Hospital

154/9, Bannerghatta Road, Opposite IIM-B, Bengaluru, Karnataka 560076

  Google Map

On appointments only : +91 9482202240